Environmental, Social And Governance Report

Overview

The report describes AIM Vaccine's 2025 vaccine development pipeline, including eight commercialised vaccines and 20 innovative candidates across multiple disease areas. It also details a three-tier ESG governance framework with the Board of Directors as the highest oversight body. The report covers 1,466 employees and provides quantified resource-use and emissions disclosures, including a 1.76% renewable energy share and 100% compliance rates for wastewater, waste gas and noise emissions.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2025
Period: 1 January 2025 – 31 December 2025
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services